Partnering Team
At Ipsen, partnering is personal and purpose led. Discover the people leading Ipsen’s externalinnovation and alliance management strategy.
“Breakthroughs happen when we collaborate withpartners who share our commitment to science,patients and delivering impact. Partnering to us,means following the right science, combining ourstrengths with those of our partners, and using ourunique capabilities to ensure medicines reachpatients, faster. Our alliances are deeply personal andbuilt for the long term. Together, we know we gofurther.”
“Having started my career as a scientist, I’ve seenfirsthand how collaboration can transform science intoreal-world impact. Our science-led approach topartnering means we seek out the boldest ideas and thegreatest minds to drive innovation in areas of highunmet medical need. Every new partnership is built on ashared ambition and a clear vision: deliveringmedicines to patients that make a real difference.”
External Innovation Team
We accelerate the most promising science through external innovation – partnering with biotech and academia to access cutting-edge innovation – combined with our internal R&D expertise.
Contact the partnering team
At Ipsen, entering partnerships is always personal. Our team is committed to success and has the expertise to deliver it. Contact us to see how together, we can accelerate innovation for patients.
David Jenkins on how we work with our partners to accelerate innovation.
Christelle Huguet on how we work withour partners to turn a molecule into amedicine.
Pipeline
Our robust development pipeline, backed by our expertise and external-innovation strategy, supports patients’ health outcomes across Oncology, Rare Disease and Neuroscience.
Pipeline
Our robust development pipeline, backed by our expertise and external innovation strategy, support patients’ health outcomes across Oncology, Rare Disease, and Neuroscience.